Company: DHR
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0000313616-25-000043
Chunk: 167

Company: DANAHER CORP /DE/
Filing Date: 2025-02-20
Form: 10-K
Item: Item 5
Chunk 167
---

•2023 gain from the resolution of a litigation contingency - 15 basis points

2024 vs. 2023 operating profit margin comparisons were favorably impacted by:

•Acquisition-related transaction costs deemed significant, settlement of pre-acquisition share-based payment awards and fair value adjustments to inventory in 2023, net of acquisition-related fair value adjustment to inventory in 2024, in each case related to the acquisition of Abcam - 100 basis points

Depreciation and amortization of intangible assets increased as a percentage of sales during 2024 as compared with 2023, primarily as a result of acquisitions.

DIAGNOSTICS

The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. 

Diagnostics Selected Financial Data

 Year Ended December 31($ in millions)202420232022Sales$9,787 $9,577 $10,849 Operating profit2,625 2,406 3,436 Depreciation 394 379 387 Amortization of intangible assets192 198 203 Operating profit as a % of sales26.8 %25.1 %31.7 %Depreciation as a % of sales4.0 %4.0 %3.6 %Amortization as a % of sales2.0 %2.1 %1.9 %

Sales Growth (Decline) and Core Sales Growth (Decline)

2024 vs. 20232023 vs. 2022Total sales growth (decline) (GAAP)2.0 %(11.5)%Impact of:Currency exchange rates 1.0 %1.0 %Core sales growth (decline) (non-GAAP)3.0 %(10.5)%

2024 Sales Compared to 2023 

Price increases in the segment did not have a significant impact on sales growth on a year-over-year basis during 2024 as compared with 2023.

During 2024, total segment sales increased 2.0% primarily as a result of increased core sales resulting from the factors discussed below.  Changes in currency exchange rates negatively impacted sales year-over-year.  Overall segment core sales growth was driven primarily by North America, partially offset by lower year-over-year demand in high-growth markets.  During the